LABFF Stock - Laboratorios Farmaceuticos Rovi, S.A.
Unlock GoAI Insights for LABFF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $763.75M | $829.51M | $817.70M | $648.68M | $419.96M |
| Gross Profit | $467.71M | $483.34M | $512.43M | $379.83M | $237.14M |
| Gross Margin | 61.2% | 58.3% | 62.7% | 58.6% | 56.5% |
| Operating Income | $179.54M | $220.25M | $255.85M | $181.39M | $74.68M |
| Net Income | $136.88M | $170.34M | $199.67M | $153.08M | $61.06M |
| Net Margin | 17.9% | 20.5% | 24.4% | 23.6% | 14.5% |
| EPS | $2.67 | $3.20 | $3.73 | $2.76 | $1.10 |
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Hibor, a low-molecular-weight heparin to prevent and treat venous thromboembolic disease; Enoxaparin biosimilar Becat, a low-molecular-weight heparin; Neparvis to treat symptomatic chronic heart failure with reduced ejection in adult patients; Absorcol, Vytorin, and Orvatez to diet in patients with hypercholesterolemia; Hirobriz Breezhaler and Ulunar Breezhaler that are long-acting bronchodilators for the maintenance treatment of chronic obstructive pulmonary diseases; Volutsa for treatment of moderate to severe storage systems symptoms and voiding symptoms associated with benign prostatic hyperplasia in men who are not responding adequately to monotherapy treatment; and Medikinet and Medicebrán to treat attention deficit hyperactivity disorder in children and teenagers. The company also markets various hospital products for imaging diagnosis, such as Iomeron and Iopamiro for computed tomography and intervention; Multihance and Prohance for magnetic resonance imaging; Sonovue for ultrasounds; and EmpowerCTA+, EmpowerMR, and CT Exprès that are contrast injection systems and compatible disposable material. It provides non-prescription pharmaceutical products; and contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, hard capsules, and sachets. The company serves wholesalers, doctors, nursing staff, pharmacists, and patients. It has a collaboration with Moderna, Inc. for manufacturing mRNA COVID-19 vaccine candidate. The company was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
Visit WebsiteEarnings History & Surprises
LABFFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Feb 23, 2026 | — | — | — | — |
Q4 2025 | Nov 6, 2025 | — | — | — | — |
Q3 2025 | Jul 24, 2025 | — | $0.50 | — | — |
Q2 2025 | May 6, 2025 | — | $0.39 | — | — |
Q1 2025 | Feb 25, 2025 | — | $0.47 | — | — |
Q4 2024 | Nov 7, 2024 | — | $1.42 | — | — |
Q3 2024 | Jul 31, 2024 | — | $0.59 | — | — |
Q2 2024 | May 8, 2024 | — | $0.31 | — | — |
Q1 2024 | Feb 27, 2024 | — | $1.09 | — | — |
Q3 2023 | Sep 30, 2023 | — | $1.03 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.39 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.97 | — | — |
Q1 2023 | Feb 21, 2023 | — | $1.58 | — | — |
Q4 2022 | Nov 4, 2022 | — | $0.78 | — | — |
Q3 2022 | Jul 27, 2022 | — | $0.54 | — | — |
Q2 2022 | May 11, 2022 | — | $1.09 | — | — |
Q1 2022 | Feb 23, 2022 | $0.69 | $1.12 | +61.6% | ✓ BEAT |
Q4 2021 | Nov 3, 2021 | — | $1.00 | — | — |
Q3 2021 | Jul 28, 2021 | — | $0.58 | — | — |
Latest News
Frequently Asked Questions about LABFF
What is LABFF's current stock price?
What is the analyst price target for LABFF?
What sector is Laboratorios Farmaceuticos Rovi, S.A. in?
What is LABFF's market cap?
Does LABFF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to LABFF for comparison